Our 📄 on recent trends in advanced therapy utilization for IBD in the US published in @JCC_IBD
@GKochharMD #siddharthsinghmd
academic.oup.com/ecco-jcc/advan…
English
Aakash Desai, MD
120 posts
Aakash Desai, MD
@akMD03
GI-IBD & Assoc. Program Director @AHNGastro || Assistant Prof. of Medicine @DrexelMedicine || Alumni @MayoClinicFLGIH @metrohealthCLE @cwrusom
Pittsburgh, PA Beigetreten Haziran 2019
642 Folgt302 Follower
Aakash Desai, MD retweetet
☀️ Idea → 🎬 ACG2024 → 📝publication!
What links EoE and IBD?
❓Do IBD patients carry a higher risk of developing EoE?
❓Risk modifiers?
❓Natural history when EoE+IBD vs EoE-only?
@akMD03 @GKochharMD @FarrayeIBD @JHashashMD
🔗 share.google/AIU7m5eo3cWLQo…
Reserve Township, PA 🇺🇸 English
GLP-1RA use and clinical outcomes in IBD: Systematic Review and Meta Analysis published in @JCC_IBD. Great collaboration with international colleagues.
academic.oup.com/ecco-jcc/advan…
English
Aakash Desai, MD retweetet
🚀Dive into the future of IBD care at the 7th Annual AHN IBD Summit happening Saturday, October 4, 2025! 🚀
Explore innovations in endoscopic management, updates on biosimilars, & IBD in pregnancy. Register now at cme.ahn.org! #IBDsummit #AHN #gastroenterology
English
Aakash Desai, MD retweetet
Efficacy of tirzepatide for weight loss and it’s comparative effectiveness to weight loss surgery in inflammatory bowel disease
@FarrayeIBD @GKochharMD #GITwitter #IBD
link.springer.com/article/10.100…
English
Welcome to our new 1st year fellows! Excited to be a part of your fellowship journey. Looking forward to working with all our fellows this year!
AHN Gastroenterology, Hepatology and Nutrition@AHNGastro
Gut feeling says these 1st year GI fellows are going to be AMAZING! 🎉 Big welcome to Dr. Jacubowsky, Dr. Gries, Dr. Cohen & Dr. Amin! Plus, HUGE congrats to @AkashGadaniMD, our new Program Director, & @akMD03, our new Associate Program Director! #GIFellows #GI #AHNToday
English
Aakash Desai, MD retweetet
Not all patients with #UC may need biological therapy but how do we know which ones do and how we counsel our #patients on natural history of #UC Check out our paper to learn more about #naturalhistory of UC
pubmed.ncbi.nlm.nih.gov/40554593/
@akMD03 @Himsikhar1
English
"Courage, hard work, and perseverance — a kid who dared to dream!"
Honored to be elected as a Full Member of the Sigma Xi Honor Research Society.
Grateful to @AHNIMres and my mentors for their unwavering support.
@AHNGastro @SigmaXiSociety @akMD03 #GITwitter
Pittsburgh, PA 🇺🇸 English
@akMD03 @IBDJournals @CrohnsColitisFn @GKochharMD @FarrayeIBD @JHashashMD @MRegueiroMD Congratulations! Well deserved
English
We are honored to receive this award from @IBDJournals and @CrohnsColitisFn! Incredibly fortunate to have @GKochharMD as a mentor. Thank you to all the co-authors for their support and expertise @FarrayeIBD @JHashashMD @MRegueiroMD
Gursimran Kochhar MD@GKochharMD
Our team won the #best clinical research award. Thanks to @IBDJournals and @CrohnsColitisFn a great team effort but a special Shout out to my colleague and partner @akMD03 for his dedication and hardwork. A true rising star in the field of #obesity and #Ibd @AHNGastro @AHNtoday
English
Our team won the #best clinical research award. Thanks to @IBDJournals and @CrohnsColitisFn a great team effort but a special Shout out to my colleague and partner @akMD03 for his dedication and hardwork. A true rising star in the field of #obesity and #Ibd @AHNGastro @AHNtoday
English
English
Congratulations @akMD03, @GKochharMD! Fantastic work 👏🏼👏🏼👏🏼
Gursimran Kochhar MD@GKochharMD
Our team won the #best clinical research award. Thanks to @IBDJournals and @CrohnsColitisFn a great team effort but a special Shout out to my colleague and partner @akMD03 for his dedication and hardwork. A true rising star in the field of #obesity and #Ibd @AHNGastro @AHNtoday
English
Great collaboration between @MilestoneIBD alumni @phillyIBDdoc
Thank you to @APandT for publishing our work! @GKochharMD @FarrayeIBD @Himsikhar1 @AHNGastro
roypounder.apt@APandT
Patients with obesity and ulcerative colitis are at an increased risk of composite outcome of steroid use, change in advanced therapy and colectomy. Read the paper by Desai et al at bit.ly/3EgU9mP #obesity #ulcerativecolitis #IBD #GItwitter
English
Aakash Desai, MD retweetet
Excited to share: Obesity assoc w worse outcomes in UC @APandT
@akMD03 @JamesLewisGIEpi @PennIBDDoc @GKochharMD @FarrayeIBD
✔️UC pts w/ BMI > 30 had inc risk of steroid use, change in therapy, and colectomy
✔️Seen in pts on vedo, UST, anti-TNF & JAKi
pubmed.ncbi.nlm.nih.gov/39844347/
English
Aakash Desai, MD retweetet
Use of #EFTR in management of #dysplasia #polyps in patients with #IBD
Initial experience
It is still early days, but it is a good choice for carefully selected patients!!
Can be organ saving
pubmed.ncbi.nlm.nih.gov/?term=Kochhar+…
@Himsikhar1 @akMD03 @AHNGastro
English
Aakash Desai, MD retweetet
Check out our new #publication looking at Ozanimod and Vedolizumab in patients with #ulcerativecolitis #ibd #bigdata from @AHNGastro @akMD03 @Himsikhar1 @FjonaTabaku @FarrayeIBD @JHashashMD pubmed.ncbi.nlm.nih.gov/39478367/
English
Aakash Desai, MD retweetet
From presenting 3️⃣ posters at Western PA ACP @ACPIMPhysicians to 1️⃣1️⃣ at @AmCollegeGastro over two back to back days, with heartfelt recognitions 🏆🎖 for our team's dedication!
@AHNIMres @AHNGastro @AHNMedicineInst
English
Aakash Desai, MD retweetet
💊Have you ever had a patient with #IBD who previously failed TOFA and wondered if there is opportunity to use UPA for treatment?
Check out our paper from the #IBD group at @MayoClinicFLGIH @FarrayeIBD @JHashashMD @ibdgijami @ChristianKarime
📖 rdcu.be/dTubC
English